Hiệu quả của việc cai thuốc lá đối với nhóm dân số có nguy cơ cao mắc ung thư phổi qua sàng lọc sớm: một nghiên cứu tổng hợp hệ thống và phân tích tổng hợp các thử nghiệm ngẫu nhiên có đối chứng đến tháng 1 năm 2022

Association AL. Lung Cancer Fact Sheet. 2020. https://www.lung.org/lung-health-and-diseases/lung-disease-lookup/lung-cancer/resource-library/lung-cancer-fact-sheet.html. Sun D, Li H, Cao M, He S, Lei L, Peng J, et al. Cancer burden in China: trends, risk factors and prevention. Cancer Biol Med. 2020;17(4):879–95. https://doi.org/10.20892/j.issn.2095-3941.2020.0387. Cataldo JK, Brodsky JL. Lung cancer stigma, anxiety, depression and symptom severity. Oncology. 2013;85(1):33–40. https://doi.org/10.1159/000350834. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19(8):1893–907. https://doi.org/10.1158/1055-9965.EPI-10-0437. Collaborators GRF. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223–49. https://doi.org/10.1016/S0140-6736(20)30752-2. Hecht SS. More than 500 trillion molecules of strong carcinogens per cigarette: use in product labelling? Tob Control. 2011;20(5):387. https://doi.org/10.1136/tc.2011.042853. Bade BC, Dela CC. Lung Cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med. 2020;41(1):1–24. https://doi.org/10.1016/j.ccm.2019.10.001. Health NCFC. The health consequences of smoking—50 years of progress: a report of the surgeon general. 2014. Condoluci A, Mazzara C, Zoccoli A, Pezzuto A, Tonini G. Impact of smoking on lung cancer treatment effectiveness: a review. Future Oncol. 2016;12(18):2149–61. https://doi.org/10.2217/fon-2015-0055. Tanner NT, Kanodra NM, Gebregziabher M, Payne E, Halbert CH, Warren GW, et al. The Association between smoking abstinence and mortality in the national lung screening trial. Am J Respir Crit Care Med. 2016;193(5):534–41. https://doi.org/10.1164/rccm.201507-1420OC. Fucito LM, Czabafy S, Hendricks PS, Kotsen C, Richardson D, Toll BA. Pairing smoking-cessation services with lung cancer screening: a clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco. Cancer Am Cancer Soc. 2016;122(8):1150–9. https://doi.org/10.1002/cncr.29926. L. JTSJ. Hutter Center for Medicare & Medicaid Services Decision memo for screening for lung cancer with low dose computed tomography (LDCT) (CAG-00439N). 2015.http://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=274. O’Dowd EL, McKeever TM, Baldwin DR, Anwar S, Powell HA, Gibson JE, et al. Author’s response: What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK? Thorax. 2015;70(2):185. https://doi.org/10.1136/thoraxjnl-2014-206638. Balata H, Evison M, Sharman A, Crosbie P, Booton R. CT screening for lung cancer: are we ready to implement in Europe? Lung Cancer. 2019;134:25–33. https://doi.org/10.1016/j.lungcan.2019.05.028. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409. https://doi.org/10.1056/NEJMoa1102873. Wood DE, Kazerooni EA, Baum SL, Eapen GA, Ettinger DS, Hou L, et al. Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(4):412–41. https://doi.org/10.6004/jnccn.2018.0020. Pistelli F, Aquilini F, Falaschi F, Puliti D, Ocello C, Lopes PA, et al. Smoking Cessation in the ITALUNG lung cancer screening: what does “teachable moment” mean? Nicotine Tob Res. 2020;22(9):1484–91. https://doi.org/10.1093/ntr/ntz148. de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, et al. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N Engl J Med. 2020;382(6):503–13. https://doi.org/10.1056/NEJMoa1911793. Iaccarino JM, Duran C, Slatore CG, Wiener RS, Kathuria H. Combining smoking cessation interventions with LDCT lung cancer screening: a systematic review. Prev Med. 2019;121:24–32. https://doi.org/10.1016/j.ypmed.2019.02.016. Cadham CJ, Jayasekera JC, Advani SM, Fallon SJ, Stephens JL, Braithwaite D, et al. Smoking cessation interventions for potential use in the lung cancer screening setting: a systematic review and meta-analysis. Lung Cancer. 2019;135:205–16. https://doi.org/10.1016/j.lungcan.2019.06.024. Frazer K, Bhardwaj N, Fox P, Niranjan V, Stokes D, Quinn S, et al. Smoking cessation interventions for smokers diagnosed with cancer: a systematic review. Lancet. 2022;400(Suppl 1):S39. https://doi.org/10.1016/S0140-6736(22)02249-8. Piñeiro B, Simmons VN, Palmer AM, Correa JB, Brandon TH. Smoking cessation interventions within the context of Low-Dose Computed Tomography lung cancer screening: a systematic review. Lung Cancer. 2016;98:91–8. https://doi.org/10.1016/j.lungcan.2016.05.028. Ostroff JS, Copeland A, Borderud SP, Li Y, Shelley DR, Henschke CI. Readiness of lung cancer screening sites to deliver smoking cessation treatment: current practices, organizational priority, and perceived barriers. Nicotine Tob Res. 2016;18(5):1067–75. https://doi.org/10.1093/ntr/ntv177. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71. Higgins JPT TJCJ. Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). 2020.www.training.cochrane.org/handbook. Buttery SC, Williams P, Mweseli R, Philip K, Sadaka A, Bartlett EJ, et al. Immediate smoking cessation support versus usual care in smokers attending a targeted lung health check: the QuLIT trial. BMJ Open Respir Res. 2022;9(1):e001030. https://doi.org/10.1136/bmjresp-2021-001030. Tremblay A, Taghizadeh N, MacEachern P, Burrowes P, Graham AJ, Lam SC, et al. Two-year follow-up of a randomized controlled study of integrated smoking cessation in a lung cancer screening program. JTO Clin Res Rep. 2021;2(2):100097. https://doi.org/10.1016/j.jtocrr.2020.100097. Lucchiari C, Masiero M, Mazzocco K, Veronesi G, Maisonneuve P, Jemos C, et al. Benefits of e-cigarettes in smoking reduction and in pulmonary health among chronic smokers undergoing a lung cancer screening program at 6 months. Addict Behav. 2020;103:106222. https://doi.org/10.1016/j.addbeh.2019.106222. Tremblay A, Taghizadeh N, Huang J, Kasowski D, MacEachern P, Burrowes P, et al. A randomized controlled study of integrated smoking cessation in a lung cancer screening program. J Thorac Oncol. 2019;14(9):1528–37. https://doi.org/10.1016/j.jtho.2019.04.024. Masiero M, Lucchiari C, Mazzocco K, Veronesi G, Maisonneuve P, Jemos C, et al. E-cigarettes may support smokers with high smoking-related risk awareness to stop smoking in the short run: preliminary results by randomized controlled trial. Nicotine Tob Res. 2019;21(1):119–26. https://doi.org/10.1093/ntr/nty047. Taylor KL, Hagerman CJ, Luta G, Bellini PG, Stanton C, Abrams DB, et al. Preliminary evaluation of a telephone-based smoking cessation intervention in the lung cancer screening setting: a randomized clinical trial. Lung Cancer. 2017;108:242–6. https://doi.org/10.1016/j.lungcan.2017.01.020. Marshall HM, Courtney DA, Passmore LH, McCaul EM, Yang IA, Bowman RV, et al. Brief tailored smoking cessation counseling in a lung cancer screening population is feasible: a pilot randomized controlled trial. Nicotine Tob Res. 2016;18(7):1665–9. https://doi.org/10.1093/ntr/ntw010. Clark MM, Cox LS, Jett JR, Patten CA, Schroeder DR, Nirelli LM, et al. Effectiveness of smoking cessation self-help materials in a lung cancer screening population. Lung Cancer. 2004;44(1):13–21. https://doi.org/10.1016/j.lungcan.2003.10.001. Joseph AM, Rothman AJ, Almirall D, Begnaud A, Chiles C, Cinciripini PM, et al. Lung Cancer Screening and Smoking Cessation Clinical Trials. SCALE (Smoking Cessation within the Context of Lung Cancer Screening) Collaboration. Am J Respir Crit Care Med. 2018;197(2):172–82. https://doi.org/10.1164/rccm.201705-0909CI. Zeliadt SB, Heffner JL, Sayre G, Klein DE, Simons C, Williams J, et al. Attitudes and perceptions about smoking cessation in the context of lung cancer screening. JAMA Intern Med. 2015;175(9):1530–7. https://doi.org/10.1001/jamainternmed.2015.3558. Shanghai Health Promotion Center serves as the Tobacco Disease Group of the Respiratory Disease Specialized Branch of the Shanghai Medical Association. Smoking cessation guide manual. Shanghai: Shanghai Scientific and Technical Publishers; 2021. p. 73+89+91. Strongin RM. E-cigarette chemistry and analytical detection. Annu Rev Anal Chem (Palo Alto Calif). 2019;12(1):23–39. https://doi.org/10.1146/annurev-anchem-061318-115329. Doering PL, Li RM. Substance-related disorders II: Alcohol, nicotine, and caffeine. In: Pharmacotherapy: A Pathophysiologic Approach. 9th ed. New York: The McGraw-Hill Companies; 2014. Fisher ML, Pauly JR, Froeliger B, Turner JR. Translational research in nicotine addiction. Cold Spring Harb Perspect Med. 2021;11(6):a039776. https://doi.org/10.1101/cshperspect.a039776. Harrell PT, Marquinez NS, Correa JB, Meltzer LR, Unrod M, Sutton SK, et al. Expectancies for cigarettes, e-cigarettes, and nicotine replacement therapies among e-cigarette users (aka vapers). Nicotine Tob Res. 2015;17(2):193–200. https://doi.org/10.1093/ntr/ntu149. Kim N, McCarthy DE, Cook JW, Piper ME, Schlam TR, Baker TB. Time-varying effects of “optimized smoking treatment” on craving, negative affect and anhedonia. Addiction. 2021;116(3):608–17. https://doi.org/10.1111/add.15232. van der Aalst CM, de Koning HJ, van den Bergh KA, Willemsen MC, van Klaveren RJ. The effectiveness of a computer-tailored smoking cessation intervention for participants in lung cancer screening: a randomised controlled trial. Lung Cancer. 2012;76(2):204–10. https://doi.org/10.1016/j.lungcan.2011.10.006. Grable JC, Lin JK, Peltzer K, Schultz R, Bugbee D, Pilipenko M, et al. Integrating tobacco dependence treatment into hospital practice using the Rochester model. J Multidiscip Healthc. 2023;16:905–11. https://doi.org/10.2147/JMDH.S400615. Caponnetto P, Campagna D, Maglia M, Benfatto F, Emma R, Caruso M, et al. Comparing the Effectiveness, Tolerability, and Acceptability of Heated Tobacco Products and Refillable Electronic Cigarettes for Cigarette Substitution (CEASEFIRE): Randomized Controlled Trial. JMIR Public Health Surveill. 2023;9:e42628. https://doi.org/10.2196/42628. Cheung KL, de Ruijter D, Hiligsmann M, Elfeddali I, Hoving C, Evers S, et al. Exploring consensus on how to measure smoking cessation. A Delphi study. BMC Public Health. 2017;17(1):890. https://doi.org/10.1186/s12889-017-4902-7. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res. 2003;5(1):13–25. Hui Z, Mi Y, Jie C, Xiao C, Yi-li C, Wei C, et al. Interpretation of“the guidelines for inclusion of patient-reported outcomes in clinical trial protocols: the SPIRIT-PRO extension.” Chin J New Drugs. 2021;30(14):1296–301. Benowitz NL, Bernert JT, Foulds J, Hecht SS, Jacob P, Jarvis MJ, et al. Biochemical verification of tobacco use and abstinence: 2019 update. Nicotine Tob Res. 2020;22(7):1086–97. https://doi.org/10.1093/ntr/ntz132. Mansueto G, Carrozzino D, Sparle CK, Cardellicchio S, Pezzuto A, Abrams K, et al. Clinimetric properties of the smoking abstinence expectancies questionnaire. Addict Behav. 2021;123:107061. https://doi.org/10.1016/j.addbeh.2021.107061. Park ER, Gareen IF, Japuntich S, Lennes I, Hyland K, DeMello S, et al. Primary care provider-delivered smoking cessation interventions and smoking cessation among participants in the national lung screening trial. JAMA Intern Med. 2015;175(9):1509–16. https://doi.org/10.1001/jamainternmed.2015.2391.